'Doctor, treat your patient, not your monitor!' Tremor-induced ECG artefacts mimicking torsades de pointes.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 24811562)

Published in BMJ Case Rep on May 08, 2014

Authors

Antonio Mirijello1, Mariella Fuorlo, Giovanni Addolorato, Raffaele Landolfi

Author Affiliations

1: Department of Internal Medicine, Catholic University of Rome, Rome, Italy.

Articles citing this

Electrocardiogram Interpretation in a Man with Alcohol Withdrawal and Hypothermia. Tex Heart Inst J (2017) 0.75

Articles cited by this

Tremor-induced ECG artifact mimicking ventricular tachycardia. Circulation (2000) 2.42

Electrocardiographic artifact. N Engl J Med (2000) 1.13

Articles by these authors

(truncated to the top 100)

Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med (2005) 4.57

Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcohol Clin Exp Res (2013) 2.84

Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study. Blood (2004) 2.64

Vascular and neoplastic risk in a large cohort of patients with polycythemia vera. J Clin Oncol (2005) 2.50

Management of alcohol dependence in patients with liver disease. CNS Drugs (2013) 2.35

Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol (2009) 2.14

Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol Alcohol (2011) 1.98

Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol (2010) 1.69

Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound. J Hepatol (2013) 1.62

Increased serum high-density lipoprotein-cholesterol concentration in celiac disease after gluten-free diet treatment correlates with body fat stores. J Clin Gastroenterol (2009) 1.54

Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns. Dig Dis Sci (2012) 1.52

Primary renal angiosarcoma: a rare malignancy. A case report and review of the literature. Urol Oncol (2006) 1.47

Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Arch Intern Med (2008) 1.34

Acute alcohol intoxication. Eur J Intern Med (2008) 1.29

The haematocrit and platelet target in polycythemia vera. Br J Haematol (2006) 1.25

Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene. Hum Genet (2001) 1.15

Effectiveness and safety of baclofen in the treatment of alcohol dependent patients. CNS Neurol Disord Drug Targets (2010) 1.11

Ghrelin system in alcohol-dependent subjects: role of plasma ghrelin levels in alcohol drinking and craving. Addict Biol (2011) 1.11

Role of GABA(B) receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics. Neurotox Res (2004) 1.11

Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. Clin Gastroenterol Hepatol (2010) 1.11

Role of feeding-related pathways in alcohol dependence: A focus on sweet preference, NPY, and ghrelin. Alcohol Clin Exp Res (2010) 1.09

Polymyalgia rheumatica in 2011. Best Pract Res Clin Rheumatol (2012) 1.05

Baclofen-induced reduction of alcohol reinforcement in alcohol-preferring rats. Alcohol (2005) 1.02

Prevention of thrombosis in polycythemia vera and essential thrombocythemia. Haematologica (2008) 1.01

Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: a case report. J Clin Psychopharmacol (2007) 1.01

The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response. Cytokine Growth Factor Rev (2013) 1.01

Safety and efficacy of GABAergic medications for treating alcoholism. Alcohol Clin Exp Res (2005) 1.01

The GABA(B) receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats. Alcohol Alcohol (2002) 1.01

Prophylaxis against venous thromboembolism in patients with cancer. N Engl J Med (2014) 0.97

Association between migraine and Celiac disease: results from a preliminary case-control and therapeutic study. Am J Gastroenterol (2003) 0.94

Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. Mediators Inflamm (2010) 0.94

Relationship between the hypothalamic-pituitary-thyroid axis and alcohol craving in alcohol-dependent patients: a longitudinal study. Alcohol Clin Exp Res (2008) 0.93

Insulin but not insulin growth factor-1 correlates with craving in currently drinking alcohol-dependent patients. Alcohol Clin Exp Res (2008) 0.93

Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels. Clin Endocrinol (Oxf) (2012) 0.92

A human laboratory pilot study with baclofen in alcoholic individuals. Pharmacol Biochem Behav (2012) 0.91

Preliminary findings on the use of metadoxine for the treatment of alcohol dependence and alcoholic liver disease. Hum Psychopharmacol (2011) 0.91

Role of trait anxiety in persistent radicular pain after surgery for lumbar disc herniation: a 1-year longitudinal study. Neurosurgery (2010) 0.91

State and trait anxiety and depression in patients with primary brain tumors before and after surgery: 1-year longitudinal study. J Neurosurg (2008) 0.90

IL-1β biological treatment of familial Mediterranean fever. Clin Rev Allergy Immunol (2013) 0.89

Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms. Intern Emerg Med (2011) 0.89

Metadoxine in acute alcohol intoxication: a double-blind, randomized, placebo-controlled study. Alcohol Clin Exp Res (2002) 0.88

Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcohol-dependent patients: a longitudinal study. Alcohol (2008) 0.88

Turning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependence. Curr Pharm Des (2010) 0.88

Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? Int J Vasc Med (2011) 0.87

Interaction of alcohol intake and cofactors on the risk of cirrhosis. Liver Int (2010) 0.86

A case of variant angina in a patient under chronic treatment with sorafenib. Nat Rev Clin Oncol (2010) 0.85

Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy. Arterioscler Thromb Vasc Biol (2013) 0.85

Coenzyme Q 10 and cardiovascular risk factors in idiopathic sudden sensorineural hearing loss patients. Otol Neurotol (2007) 0.85

Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. Clin Transl Gastroenterol (2012) 0.85

Alcohol use disorders in the elderly: a brief overview from epidemiology to treatment options. Exp Gerontol (2012) 0.85

The Italian version of the Obsessive-Compulsive Drinking Scale: validation, comparison with the other versions, and difference between type 1- and type 2-like alcoholics. Drug Alcohol Depend (2004) 0.85

Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery. Haematologica (2007) 0.84

Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms. Dig Liver Dis (2012) 0.83

Distinct expression of cyclooxygenase-1 and -2 in the human thymus. Eur J Immunol (2002) 0.83

Autoimmune hemolytic anemia with gel-based immunohematology tests. Am J Clin Pathol (2013) 0.83

Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomised comparative study. Eur Neuropsychopharmacol (2007) 0.82

Coeliac disease and hearing loss: preliminary data on a new possible association. Scand J Gastroenterol (2007) 0.82

Superior vena cava thrombosis treated by angioplasty and stenting in a cirrhotic patient with peritoneovenous shunt. Ann Thorac Cardiovasc Surg (2008) 0.82

Reduced plasma ghrelin concentration in celiac disease after gluten-free diet treatment. Scand J Gastroenterol (2005) 0.81

Baclofen for outpatient treatment of alcohol withdrawal syndrome. J Fam Pract (2005) 0.81

NSAID enteropathy: could probiotics prevent it? J Gastroenterol (2012) 0.81

Identification and management of alcohol withdrawal syndrome. Drugs (2015) 0.81

A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease. Mol Biol Rep (2012) 0.81

Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an update. Eur J Gastroenterol Hepatol (2010) 0.81

IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII. J Clin Invest (2015) 0.81

Serotonin transporter (SERT) brain density and neurobiological Cloninger subtypes model: a lesson by human autoradiography studies. Alcohol Alcohol (2008) 0.80

High prevalence of antiendothelial cell antibodies in migraine. Headache (2002) 0.80

Fecal calprotectin concentrations in alcoholic patients: a longitudinal study. Eur J Gastroenterol Hepatol (2011) 0.80

[Evaluation of liver fibrosis in clinical practice]. Recenti Prog Med (2006) 0.79

Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban. Thromb Haemost (2003) 0.79

Suppression of craving for gamma-hydroxybutyric acid by naltrexone administration: three case reports. Clin Neuropharmacol (2005) 0.79

Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity. Eur Neuropsychopharmacol (2011) 0.79

Sodium oxybate in maintaining alcohol abstinence in alcoholic patients according to Lesch typologies: a pilot study. J Psychopharmacol (2013) 0.79

A new mutation of Wilson's disease P-type ATPase gene in a patient with cirrhosis and coombs-positive hemolytic anemia. Dig Dis Sci (2006) 0.79

Baseline von Willebrand factor plasma levels and no-reflow phenomenon after primary percutaneous coronary intervention for ST segment elevation myocardial infarction. Int J Cardiol (2009) 0.79

Pathophysiology of thrombosis in myeloproliferative neoplasms. Haematologica (2011) 0.79

Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention. Expert Opin Pharmacother (2013) 0.79

Evaluation of the albumin-gamma-glutamyltransferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. J Gastroenterol Hepatol (2003) 0.79

TNFRSF11B gene polymorphisms increased risk of peripheral arterial occlusive disease and critical limb ischemia in patients with type 2 diabetes. Acta Diabetol (2014) 0.79

Celiac disease: from gluten to skin. Expert Rev Clin Immunol (2009) 0.78

Metabolic and nutritional features in adult celiac patients. Dig Dis (2008) 0.78

Analysis of the T1288R mutation of the Wilson disease ATP7B gene in four generations of a family: possible genotype-phenotype correlation with hepatic onset. Dig Dis Sci (2007) 0.78

Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X. Int J Cardiol (2005) 0.78

Celiac disease and skin disorders. Pediatr Dermatol (2005) 0.78

Combined role of the Lewis antigenic system, Chlamydia pneumoniae, and C-reactive protein in unstable angina. J Am Coll Cardiol (2003) 0.78

Sodium oxybate in the treatment of alcohol withdrawal syndrome: a randomized double-blind comparative study versus oxazepam. The GATE 1 trial. CNS Drugs (2014) 0.78

Tolerance to baclofen's sedative effect in alcohol-addicted patients: no dissipation after a period of abstinence. Psychopharmacology (Berl) (2004) 0.77

Is cortisol involved in the alcohol-related fat mass impairment? A longitudinal clinical study. Alcohol Alcohol (2009) 0.77

In vivo and in vitro effects of different anaesthetics on platelet function. Br J Haematol (2004) 0.77

Phytotherapeutic approach to alcohol dependence: new old way? Phytomedicine (2009) 0.77

MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivation. Am J Hematol (2003) 0.77

Liver transplantation in alcoholic patients--reply. Alcohol Clin Exp Res (2013) 0.77

Alpe adria report 2010 - conclusions and recommendations for the treatment of alcohol dependence. Front Psychiatry (2011) 0.77

Relationship between changes in platelet reactivity and changes in platelet receptor expression induced by physical exercise. Thromb Res (2007) 0.76

Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotype. Blood (2002) 0.76

An open randomized study of the treatment of escitalopram alone and combined with gamma-hydroxybutyric acid and naltrexone in alcoholic patients. Pharmacol Res (2008) 0.76

Link between insulin and metabolic disorders in cancer: does leptin play a key role? Breast Cancer Res Treat (2008) 0.75

Baclofen use in the treatment of alcohol delirium tremens. Arch Intern Med (2005) 0.75

Cardiovascular Involvement in Erdheim-Chester Disease: A Case Report and Review of the Literature. Medicine (Baltimore) (2015) 0.75

Celiac disease. N Engl J Med (2008) 0.75